Merck & Co. Inc. buy Argus
Start price
07.06.24
/
50%
€119.60
Target price
07.06.25
-
Performance (%)
-42.31%
End price
08.06.25
€69.00
Summary
This prediction ended on 08.06.25 with a price of €69.00. The BUY prediction by Argus for Merck & Co. Inc. performed very badly with a performance of -42.31%. A total of €2.99 was paid as dividends for this prediction. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% | 20.321% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by Argus for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten